Literature DB >> 22209297

[Antidepressant management strategy from the patient perspective: struggling internally and externally].

Vinita Mahtani-Chugani1, Emilio Sanz-Alvarez, Carlos de Las Cuevas-Castresana.   

Abstract

OBJECTIVE: To identify the consumption pathway and strategies of coping with antidepressants use from the patients perspective.
DESIGN: Qualitative research.
SETTING: Tenerife. SAMPLING: Theoretical sampling until saturation.
METHOD: A total of 17 open interviews with patients who consumed antidepressants whether combined with tranquilisers or not. The age range was between 35-85 years, and there were 13 women. Ten lived in a more urban setting and the rest in rural areas. Interviews were audio-recorded, transcribed verbatim and analysed using a modified Grounded Theory supported by the software program ATLAS.ti.
RESULTS: The process identified as coping with antidepressants, was called "struggling internally and externally." It consisted of the individual assessment of the benefits and risks of medication use (internal struggle), addressing stigma and social pressure (external struggle). The outcome of the assessment made by patients may lead to different strategies for adjusting to drug treatment: "unconditional acceptance", "resigned acceptance" or "forced acceptance".
CONCLUSIONS: Understanding the evaluation process that the patient needs to go through, given the internal and external struggle in which they are immersed, can be useful to develop interventions that improve medication use. In fact, physicians have an important role, although not always explicitly sought in resolving the dilemma posed by patients using antidepressant drugs and, therefore, reducing the length of patient suffering.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209297      PMCID: PMC7025173          DOI: 10.1016/j.aprim.2011.10.003

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  8 in total

1.  [Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study].

Authors:  Josep M Haro; Concepció Palacín; Gemma Vilagut; Montse Martínez; Mariola Bernal; Inma Luque; Miquel Codony; Montse Dolz; Jordi Alonso
Journal:  Med Clin (Barc)       Date:  2006-04-01       Impact factor: 1.725

2.  Continuity of antidepressant treatment for adults with depression in the United States.

Authors:  Mark Olfson; Steven C Marcus; Michael Tedeschi; George J Wan
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  [European Study of the Epidemiology of Mental Disorders (ESEMeD): contributions for the mental health in Spain].

Authors:  J J López-Ibor; J Alonso; J M Haro
Journal:  Actas Esp Psiquiatr       Date:  2007-09       Impact factor: 1.196

Review 4.  Resisting medicines: a synthesis of qualitative studies of medicine taking.

Authors:  Pandora Pound; Nicky Britten; Myfanwy Morgan; Lucy Yardley; Catherine Pope; Gavin Daker-White; Rona Campbell
Journal:  Soc Sci Med       Date:  2005-01-26       Impact factor: 4.634

5.  Dropouts versus completers among chronically depressed outpatients.

Authors:  Bruce A Arnow; Christine Blasey; Rachel Manber; Michael J Constantino; John C Markowitz; Daniel N Klein; Michael E Thase; James H Kocsis; A John Rush
Journal:  J Affect Disord       Date:  2006-07-20       Impact factor: 4.839

Review 6.  Depression and public health: an overview.

Authors:  Paolo Cassano; Maurizio Fava
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

Review 7.  Users perception of risk and benefits of mood modifying drugs.

Authors:  Vinita Mahtani-Chugani; Emilio J Sanz
Journal:  Curr Clin Pharmacol       Date:  2011-05

Review 8.  "Medication career" or "moral career"? The two sides of managing antidepressants: a meta-ethnography of patients' experience of antidepressants.

Authors:  Alice Malpass; Alison Shaw; Debbie Sharp; Fiona Walter; Gene Feder; Matthew Ridd; David Kessler
Journal:  Soc Sci Med       Date:  2008-11-17       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.